publication venue for Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems. 5:e00339-e00339. 2017
has subject area 0304 Medicinal and Biomolecular Chemistry (FoR) 1115 Pharmacology and Pharmaceutical Sciences (FoR)